Colorectal carcinogenesis. 1. Hereditary predisposition to colorectal cancer

被引:10
|
作者
Karoui, M.
Tresallet, C.
Brouquet, A.
Radvanyi, H.
Penna, C.
机构
[1] Hop Henri Mondor, Serv Chirurg Digest, F-94010 Creteil, France
[2] Hop La Pitie Salpetriere, Serv Chirurg Digest & Endosrinienne, Paris, France
[3] Hop Ambroise Pare, Federatr Special Digest, Boulogne, France
[4] Hop Ambroise Pare, Serv Biochim & Genet Mol, Boulogne, France
来源
JOURNAL DE CHIRURGIE | 2007年 / 144卷 / 01期
关键词
colon; rectum; cancer; genetics; epidemiology; carcinogenesis;
D O I
10.1016/S0021-7697(07)89450-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Tumors arising sporadically represent 70-80% of colorectal cancer (CRC). The two best defined forms of inherited CRC-familial multiple polyposis (FMP) and Hereditary Non-Polyposis Colon Cancer (HNPCC) account respectiveiv for < 1% and 2-3% of CRC. These rare genetic syndromes (FMP, HNPCC, Peutz-Jeghers Syndrome) are caused by major predisposing gene mutations (APC gene, MMR gene, BMPR1A. SIMAD4,...) and local environmental factors play only a minor role. In the sporadic forms of CRC, 25% have significant genetic predisposition probably related to alleles with weak penetration (APC*I1307K, TGF beta R1*6Ala...) and are more strongly affected by environmental factors.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 50 条
  • [1] Microsatellite instability in hereditary colorectal carcinogenesis.
    Pedroni, M
    Percesepe, A
    Sala, E
    Menigatti, M
    Rossi, G
    Benatti, P
    Dibetta, E
    Nascinbeni, R
    Di Gregorio, C
    Losi, L
    de Leon, MP
    Roncucci, L
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 80 - 80
  • [2] Aspirin, NSAIDs and colorectal carcinogenesis.
    Benamouzig, R
    Chaussade, S
    Little, J
    Munoz, N
    Rautureau, J
    Couturier, D
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (03): : 188 - 196
  • [3] Hereditary colorectal carcinogenesis
    Blaeker, Hendrik
    [J]. PATHOLOGIE, 2023, 44 (05): : 311 - 317
  • [4] Histone phosphorylation: prognostic value in colorectal carcinogenesis.
    Ghosh, Bimal C.
    Zak, Yulia
    Wu, James T.
    Romano, Carol
    Biagini, Blanche
    Seymour, Andrew
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [5] Analysis of the Selenoprotein P promoter in colorectal carcinogenesis.
    Al-Taie, O
    Moerk, H
    Treis, H
    Seufert, J
    Eussner, U
    Ueceyler, N
    Thalheimer, A
    Mostert, V
    Scheurlen, M
    Koehrle, J
    Jakob, F
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A271 - A271
  • [6] GENETIC PREDISPOSITION OR NUTRITION IN COLORECTAL CARCINOGENESIS
    GRANDJOUAN, S
    [J]. PATHOLOGIE BIOLOGIE, 1991, 39 (01): : 78 - 80
  • [7] Genetic testing of atypical families with hereditary predisposition to colorectal cancer
    Soravia, C
    DosSantos, C
    Berk, T
    Madlensky, L
    Mitri, A
    Xia, L
    Gallinger, S
    Cohen, Z
    Bapat, B
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A660 - A660
  • [8] CRITERIA OF HEREDITARY PREDISPOSITION TO HEREDITARY NONPOLYPOSIS COLORECTAL CANCERS
    BIGNON, YJ
    BERNARD, D
    SOBOL, H
    [J]. BULLETIN DU CANCER, 1994, 81 (01) : 60 - 65
  • [9] Omeprazole may inhibit initiation of experimental colorectal carcinogenesis.
    Duncan, JR
    Penman, ID
    Oein, K
    O'Dwyer, PJ
    McGregor, JR
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1386 - A1386
  • [10] Clinical significance of ZHX2 in colitis and colorectal carcinogenesis.
    Bao, Yonghua
    Guo, Yongchen
    Yang, Wancai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)